Keywords: salix, rifaximin, effective, ph, ii, ibs-d, study

Salix' rifaximin effective in Ph II IBS-d study

Article | 13 October 2008

Print This

The USA's Salix Pharmaceuticals says findings from two analyses of a Phase II trial demonstrate the utility of rifaximin in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in